HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gülnur Emingil Selected Research

Aggressive Periodontitis (Periodontosis)

11/2020Effect of non-surgical periodontal treatment on gingival crevicular fluid hypoxia inducible factor-1 alpha, vascular endothelial growth factor and tumor necrosis factor-alpha levels in generalized aggressive periodontitis patients.
1/2018Alarm anti-protease trappin-2 negatively correlates with proinflammatory cytokines in patients with periodontitis.
6/2015The utility of gingival crevicular fluid matrix metalloproteinase-8 response patterns in prediction of site-level clinical treatment outcome.
8/2014Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy.
6/2011A novel p.S34N mutation of CAMP gene in patients with periodontal disease.
5/2011Toll like receptor 4 and membrane-bound CD14 expressions in gingivitis, periodontitis and CsA-induced gingival overgrowth.
4/2009Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis.
12/2007Matrix metalloproteinase-2, -9, and -12 gene polymorphisms in generalized aggressive periodontitis.
10/2007Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis.
5/2007Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gülnur Emingil Research Topics

Disease

23Gingivitis
01/2021 - 08/2005
22Periodontal Diseases (Periodontal Disease)
04/2021 - 01/2004
22Chronic Periodontitis
01/2020 - 09/2002
21Periodontitis
01/2021 - 03/2004
17Aggressive Periodontitis (Periodontosis)
11/2020 - 09/2002
14Inflammation (Inflammations)
04/2021 - 04/2006
11Gingival Overgrowth
12/2016 - 06/2005
5Hemorrhage
01/2020 - 10/2004
2Hypoxia (Hypoxemia)
11/2020 - 01/2019
2Fibrosis (Cirrhosis)
12/2016 - 09/2015
2Periodontal Pocket (Periodontal Pockets)
07/2006 - 10/2004
1Persistent Infection
01/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016
1Infections
03/2016
1Calculi (Calculus)
06/2011
1Myocardial Infarction
05/2011
1Alveolar Bone Loss
10/2009

Drug/Important Bio-Agent (IBA)

11Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2016 - 06/2005
9Matrix Metalloproteinases (MMPs)IBA
04/2021 - 10/2004
6CytokinesIBA
01/2020 - 05/2009
5Biomarkers (Surrogate Marker)IBA
04/2021 - 05/2011
4Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
04/2021 - 01/2004
4Tacrolimus (Prograf)FDA LinkGeneric
03/2015 - 03/2008
4DNA (Deoxyribonucleic Acid)IBA
06/2011 - 04/2006
4Doxycycline (Periostat)FDA LinkGeneric
03/2011 - 01/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020 - 10/2009
3Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2020 - 01/2011
3OsteocalcinIBA
01/2020 - 01/2011
3Peptide Hydrolases (Proteases)FDA Link
01/2018 - 04/2006
3InterleukinsIBA
01/2018 - 10/2009
3Interleukin-6 (Interleukin 6)IBA
09/2015 - 05/2010
3Tissue Inhibitor of Metalloproteinase-1IBA
08/2014 - 12/2006
3ChlorhexidineIBA
05/2014 - 05/2009
3OsteoprotegerinIBA
05/2011 - 05/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
05/2010 - 04/2007
3Plasminogen Activators (Plasminogen Activator)IBA
05/2010 - 04/2007
3Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2008 - 09/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 01/2019
2Collagen Type I (Type I Collagen)IBA
01/2020 - 03/2014
2Thiobarbituric Acid Reactive SubstancesIBA
11/2017 - 07/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2016 - 07/2015
2Chemokine CCL5IBA
09/2016 - 10/2004
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2016 - 10/2004
2Proteins (Proteins, Gene)FDA Link
09/2016 - 05/2011
2Pharmaceutical PreparationsIBA
03/2014 - 06/2005
2Tuberculin (PPD)IBA
06/2011 - 09/2006
2CathelicidinsIBA
06/2011 - 06/2009
2LigandsIBA
05/2011 - 05/2007
2ChemokinesIBA
03/2011 - 11/2006
2Peptides (Polypeptides)IBA
02/2010 - 08/2005
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2009 - 03/2009
2AngiotensinogenIBA
04/2009 - 03/2009
2Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
10/2008 - 03/2008
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2008 - 12/2007
2Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
03/2008 - 12/2006
2Plasminogen Activator Inhibitor 1IBA
07/2007 - 04/2007
2KalininIBA
07/2006 - 10/2004
2Proteoglycans (Proteoglycan)IBA
06/2005 - 03/2004
1collagen type I trimeric cross-linked peptideIBA
01/2020
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Oxidants (Oxidizing Agents)IBA
11/2017
1AntioxidantsIBA
11/2017
1TransglutaminasesIBA
12/2016
1Glucose (Dextrose)FDA LinkGeneric
09/2016
1Macrophage Migration-Inhibitory FactorsIBA
09/2016
1Melanocyte-Stimulating Hormones (MSH)IBA
09/2016
1Sodium Glutamate (Accent)IBA
09/2016
1Triglycerides (Triacylglycerol)IBA
09/2016
1Dinoprostone (PGE2)FDA Link
03/2016
1Biological ProductsIBA
03/2016
1hydroxide ionIBA
03/2016
18-Hydroxy-2'-DeoxyguanosineIBA
07/2015
1Glutathione PeroxidaseIBA
07/2015
1Antimicrobial PeptidesIBA
03/2015
1Interleukin-1 (Interleukin 1)IBA
01/2015
1Interleukin-33IBA
01/2015
1IntegrinsIBA
03/2014
1Cathepsin CIBA
01/2014
1EnzymesIBA
01/2014
1Myeloblastin (Proteinase 3)IBA
01/2014
1Azithromycin (Zithromax)FDA LinkGeneric
12/2012
1Leukemia Inhibitory FactorIBA
10/2012
1Interleukin-11 (Interleukin 11)IBA
10/2012
1Oncostatin MIBA
10/2012
1Toll-Like Receptor 4IBA
05/2011
1Peroxidase (Myeloperoxidase)IBA
10/2010
1Prostaglandins EIBA
05/2010
1ProstaglandinsIBA
05/2010
1human neutrophil peptide 1IBA
02/2010
1AdrenomedullinIBA
02/2010
1LipopolysaccharidesIBA
10/2009
1RANK LigandIBA
10/2009
1Nitric Oxide Synthase (NO Synthase)IBA
10/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2009
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
10/2009

Therapy/Procedure

13Therapeutics
11/2020 - 01/2004
3Root Planing
03/2011 - 01/2004
2Aftercare (After-Treatment)
06/2005 - 03/2004
1Debridement
01/2020